Healio: No difference in sustained health status improvements in TAVR vs. surgical AVR

October 1, 2020

Patients who had transcatheter aortic valve replacement (TAVR) had similar health status after five years with those who had surgical AVR, although there was a short-term health status benefit in the TAVR group, according to a new study.

Dr. Suzanne Arnold, cardiologist at Saint Luke’s Mid America Heart Institute, and colleagues studied high-risk patients with severe aortic stenosis who had either TAVR or surgical AVR.

"Surviving patients treated with either TAVR or surgical AVR had substantial improvements in disease-specific and generic health status," Dr. Arnold said. "These improvements were maximal at approximately 6 to 12 months and maintained through 2 years with gradual decline in physical health status thereafter."

Read the full Healio article: No difference in sustained health status improvements in TAVR vs. surgical AVR

Related Content

Healio: PET may be beneficial to guide revascularization strategy for CAD
PET perfusion and flow assessment may guide revascularization strategies for patients with carotid artery disease (CAD), according to a presentation at the Scientific Session and Exhibition of the American Society of Nuclear Cardiology.
KSHB: Saint Luke's Innovates Heart and Brain Procedures Using 3-D Technology
Saint Luke's Innovating Heart and Brain Surgery with 3D printing
Daily Mail TV: Twist on the Mediterranean diet may be best for health
A review of research in the Journal of the American College of Cardiologists suggests a Pesco-Mediterranean diet may be best for your health. Dr. James O'Keefe explains why.